Partnership to Advance Cardiovascular Health retweeted
Congratulations to @advcardiohealth and @HeartNurses for a wonderful annual meeting at #AHA26
✅ Inspiring panel with @RepChuyGarcia
✅ Important work with @FamilyHeartFdn on LDL quality measures
✅ Exciting to hear about new legislation to cover Lp(a) testing!
@ycommodore
Looking forward to a great night at PACH’s 2026 AHA Dinner at @AdlerPlanet in Chicago! We are kicking things off with opening remarks from PACH President Dharmesh Patel, MD.
#AHA26
“I’m very conscious of health disparities, in my community and beyond. I’m also mindful that working families are just trying to survive. They put their health last.”
@RepChuyGarcia calls for bipartisan collaboration to make care work for every family. #AHA26
That’s a wrap! Thank you to everyone who attended PACH’s 2026 AHA Dinner with @HeartNurses in Chicago. Thank you @RepChuyGarcia, Yvonne Commodore-Mensah & Ozzie Giglio for a powerful conversation! #AHA26
#Hypertension is a common condition. But when it comes to managing it, each patients’ struggle can be different.
Watch to learn more: bit.ly/44dhYa9
Amyloidosis can affect anyone, but it doesn’t affect everyone equally. In the U.S., the most common form of hereditary ATTR amyloidosis is more prevalent among African Americans and men.
Because symptoms often resemble other conditions, diagnosis is frequently delayed until organ damage has already occurred. PACH supports policies that promote awareness, earlier diagnosis and expanded access to testing and treatment.
Read PACH’s Amyloidosis 101 one-pager: bit.ly/4jRFxNu
For patient advocate Giselle Benmoin, a diagnosis of hereditary ATTR #amyloidosis marked the start of a new journey.
Watch her story and learn how this rare, progressive disease can affect the heart: bit.ly/3W9Ydyd
#DYK? Over 6 million Americans live with heart failure.
Watch to learn more about the signs and symptoms of #HeartFailure: bit.ly/4kwsZZo
#Amyloidosis is a serious, rare disease caused by misfolded proteins that form amyloid deposits in tissues and organs.
Greater awareness, early genetic testing and proactive screening can help shorten the diagnostic journey for individuals and families affected by ATTR amyloidosis.
Read more in PACH's new policy brief: bit.ly/4BwmJtt
The bipartisan #MINIAct would allow more time for research, investment and infrastructure for #GeneticallyTargetedTechnologies, a game-changing option for heart patients.
Learn more: bit.ly/4248Jqb
Today is #AmyloidosisAwarenessDay!
Hear from patient advocate Ozzie Giglio as he speaks about his journey after being diagnosed with cardiac amyloidosis.
Watch to learn more: bit.ly/3GRJO2s
Lend your voice in support of medication access and affordability for all Medicare beneficiaries. Ask your members of Congress to hold @CMSGov accountable and ensure that Medicare drug price negotiation lowers out-of-pocket costs for patients.
Take action, send a letter today: bit.ly/4h4bot4














